As of June 17, 2025, HST Global Inc (HSTC) reports a Gross Margin of -11.43%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing HST Global Inc's Gross Margin to Peers
To better understand HST Global Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| HST Global Inc (HSTC) | -11.43% |
| Arno Therapeutics Inc (ARNI) | 7775.20% |
| Rocket Pharmaceuticals Inc (RCKT) | 7775.20% |
| W World Corp (WWHC) | 7775.20% |
| Atreca Inc (BCEL) | 7775.20% |
| Baseline Productions Inc (BSSP) | 7775.20% |
Compared to its competitors, HST Global Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.